Home / Business and Economy / Global Pharma Giants Forge China Healthcare Ecosystems
Global Pharma Giants Forge China Healthcare Ecosystems
7 Nov
Summary
- Multinational medical companies collaborate to build China's healthcare ecosystem.
- CIIE serves as a key platform for linking Chinese government, hospitals, and businesses.
- Companies like Merck, Takeda, Gilead, Roche, and GSK showcase innovations and partnerships.
Multinational medical companies are strengthening collaborations within China's burgeoning healthcare sector at the ninth China International Import Expo (CIIE) in Shanghai. The expo serves as a crucial nexus, connecting government bodies, hospitals, and businesses with the world's leading pharmaceutical and medical technology firms.
Companies like Merck Healthcare are emphasizing an integrated ecosystem approach, partnering with entities such as Alibaba Health and the China Alliance for Rare Diseases to improve public health education and rare disease care. Takeda is engaged in discussions focused on medical innovation, capacity building, and patient services, aiming to accelerate the implementation of new healthcare solutions.
Gilead Sciences highlighted China as a core strategic market, seeking to deepen cooperation with local firms to foster a balanced and efficient healthcare system. Roche Pharmaceuticals launched an influenza season protection initiative, creating a new ecosystem for flu prevention and treatment. GSK convened experts to discuss shifting the health system towards prevention and whole-life-cycle management, including initiatives focused on AIDS prevention and treatment.
